Exhibit 4.1


DESCRIPTION
OF REGISTRANT’S SECURITIES


The following summary
of Opes Acquisition Corp.’s securities is based on and qualified by the Company’s Amended and Restated Certificate
of Incorporation (the “Amended and Restated Charter”). References to the “Company” and to “we,”
“us,” and “our” refer to Opes Acquisition Corp.” 


General


As of December 31,
2019, the Company is authorized to issue 100,000,000 shares of common stock, par value $0.0001 and 10,000,000 shares of preferred
stock, par value $0.0001. There are no shares of preferred stock currently outstanding.


Units


Each unit consists
of one share of common stock and one-half of one warrant. Each whole warrant entitles the holder to purchase one share of
common stock.


Common Stock


Our stockholders of
record are entitled to one vote for each share held on all matters to be voted on by stockholders. In connection with any vote
held to approve our initial business combination, our stockholders prior to our initial public offering (“IPO”), as
well as all of our officers and directors, have agreed to vote their respective shares of common stock owned by them immediately
prior to the IPO and any shares purchased following the IPO in the open market in favor of the proposed business combination.


Our board of directors
is divided into three classes, each of which will generally serve for a term of three years with only one class of directors being
elected in each year. There is no cumulative voting with respect to the election of directors, with the result that the holders
of more than 50% of the shares eligible to vote for the election of directors can elect all of the directors.


Pursuant to our Amended
and Restated Charter, if we do not consummate an initial business combination by June 18, 2020 (or such later date as approved
by our stockholders), our corporate existence will cease except for the purposes of winding up our affairs and liquidating. If
we are forced to liquidate prior to an initial business combination, our public stockholders are entitled to share ratably in the
trust account, based on the amount then held in the trust account. Our stockholders prior to the IPO, officers and directors have
agreed to waive their rights to participate in any liquidation distribution from the trust account occurring upon our failure to
consummate an initial business combination with respect to the founder’s common stock and private shares. Our initial stockholders,
officers and directors will therefore not participate in any liquidation distribution from the trust account with respect to such
shares. They will, however, participate in any liquidation distribution from the trust account with respect to any shares of common
stock acquired following our IPO.






     


     


    

 


Our stockholders have
no conversion, preemptive or other subscription rights and there are no sinking fund or redemption provisions applicable to the
shares of common stock, except that public stockholders have the right to sell their shares to us in a tender offer or have their
shares of common stock converted to cash equal to their pro rata share of the trust account if they vote on the proposed business
combination in connection with such business combination and the business combination is completed. Public stockholders who sell
or convert their stock into their share of the trust account still have the right to exercise the warrants that they received as
part of the units.


 If we seek to
amend any provisions of our Amended and Restated Charter that would affect our public stockholders’ ability to convert their
shares in connection with a business combination as described herein or affect the substance or timing of our obligation to redeem
100% of our public shares if we do not complete a business combination by June 18, 2020 (or such later date as approved by our
stockholders), we will provide public stockholders with the opportunity to convert their public shares in connection with any such
vote. 


Preferred Stock


Our Amended and Restated
Charter authorizes the issuance of 10,000,000 shares of preferred stock with such designation, rights and preferences as may
be determined from time to time by our board of directors. Our board of directors is empowered, without stockholder approval, to
issue preferred stock with dividend, liquidation, conversion, voting or other rights which could adversely affect the voting power
or other rights of the holders of common stock. However, the underwriting agreement prohibits us, prior to a business combination,
from issuing preferred stock which participates in any manner in the proceeds of the trust account, or which votes as a class with
the common stock on a business combination. We may issue some or all of the preferred stock to effect a business combination. In
addition, the preferred stock could be utilized as a method of discouraging, delaying or preventing a change in control of us.
Although we do not currently intend to issue any shares of preferred stock, we cannot assure you that we will not do so in the
future.


Warrants


Each warrant entitles
the registered holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment as discussed
below. However, no warrants will be exercisable for cash unless we have an effective and current registration statement covering
the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock.
Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the public
warrants is not effective within a specified period following the consummation of our initial business combination, warrant holders
may, until such time as there is an effective registration statement and during any period when we shall have failed to maintain
an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9)
of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders
will not be able to exercise their warrants on a cashless basis. In the event of such a cashless exercise, each holder would pay
the exercise price by surrendering the warrants for that number of shares of common stock equal to the quotient obtained by dividing
(x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise
price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market
value” for this purpose will mean the average reported last sale price of the shares of common stock for the 5 trading days
ending on the trading day prior to the date of exercise. The warrants will expire on the fifth anniversary of our completion of
an initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.






     


     


    

 


The warrants included
in units issued in a private placement simultaneously with the IPO (“private warrants”), as well as any warrants underlying
additional units we issue in payment of working capital loans made to us, will be identical to the warrants underlying the units
offered in our IPO except that such warrants will be exercisable for cash or on a cashless basis, at the holder’s option,
and will not be redeemable by us, in each case so long as they are still held by the initial holder or its permitted transferees.


We may call the warrants
for redemption (excluding the private warrants and any warrants underlying additional units issued in payment of working capital
loans made to us but including any outstanding warrants issued upon exercise of the unit purchase option issued to EarlyBirdCapital),
in whole and not in part, at a price of $0.01 per warrant, (i) at any time after the warrants become exercisable, (ii) upon not
less than 30 days’ prior written notice of redemption to each warrant holder after the warrants become exercisable, (iii)
 if, and only if, the reported last sale price of the shares of common stock equals or exceeds $18.00 per share (as adjusted
for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period
commencing after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant
holders, and (iv) if, and only if, there is a current registration statement in effect with respect to the shares of common stock
underlying such warrants.


The right to exercise
will be forfeited unless the warrants are exercised prior to the date specified in the notice of redemption. On and after the redemption
date, a record holder of a warrant will have no further rights except to receive the redemption price for such holder’s warrant
upon surrender of such warrant.


If we call the warrants
for redemption as described above, our management will have the option to require all holders that wish to exercise warrants to
do so on a “cashless basis.” In such event, each holder would pay the exercise price by surrendering the warrants for
that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common
stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market
value” (defined below) by (y) the fair market value. The “fair market value” for this purpose shall mean the
average reported last sale price of the shares of common stock for the 5 trading days ending on the third trading day prior to
the date on which the notice of redemption is sent to the holders of warrants.


The exercise price
and number of shares of common stock issuable on exercise of the warrants may be adjusted in certain circumstances including in
the event of a stock dividend, extraordinary dividend or our recapitalization, reorganization, merger or consolidation. However,
the warrants will not be adjusted for issuances of shares of common stock at a price below their respective exercise prices.






     


     


    

 


Dividends


We have not paid any
cash dividends on our shares of common stock to date and do not intend to pay cash dividends prior to the completion of a business
combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements
and general financial condition subsequent to completion of a business combination. The payment of any dividends subsequent to
a business combination will be within the discretion of our then board of directors. It is the present intention of our board of
directors to retain all earnings, if any, for use in our business operations and, accordingly, our board does not anticipate declaring
any dividends in the foreseeable future.


Listing of Securities


Our units, common
stock, and warrants are listed on the Nasdaq Stock Market LLC under the symbols “OPESU,” “OPES,” and “OPESW,”
respectively.


Delaware Anti-Takeover
Law


Staggered Board
of Directors


Our Amended and Restated
Charter provides that our board of directors will be classified into three classes of directors of approximately equal size. As
a result, in most circumstances, a person can gain control of our board only by successfully engaging in a proxy contest at two
or more annual meetings.


Special Meeting
of Stockholders


Our bylaws provide
that special meetings of our stockholders may be called only by a majority vote of our board of directors, by our president or
by our chairman or by our secretary at the request in writing of stockholders owning a majority of our issued and outstanding capital
stock entitled to vote.


Advance Notice
Requirements for Stockholder Proposals and Director Nominations


Our bylaws provide
that stockholders seeking to bring business before our annual meeting of stockholders, or to nominate candidates for election as
directors at our annual meeting of stockholders must provide timely notice of their intent in writing. To be timely, a stockholder’s
notice will need to be delivered to our principal executive offices not later than the close of business on the 60th day
nor earlier than the close of business on the 90th day prior to the scheduled date of the annual meeting of stockholders.
In the event that less than 70 days’ notice or prior public disclosure of the date of the annual meeting of stockholders
is given, a stockholder’s notice shall be timely if delivered to our principal executive offices not later than the 10th day
following the day on which public announcement of the date of our annual meeting of stockholders is first made or sent by us. Our
bylaws also specify certain requirements as to the form and content of a stockholders’ meeting. These provisions may preclude
our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at our
annual meeting of stockholders.






     


     


    

 


Authorized but
Unissued Shares


Our authorized but
unissued common stock and preferred stock are available for future issuances without stockholder approval and could be utilized
for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit
plans. The existence of authorized but unissued and unreserved common stock and preferred stock could render more difficult or
discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.


Exclusive Forum
Selection


Our Amended and Restated
Charter requires, to the fullest extent permitted by law, that derivative actions brought in our name, actions against directors,
officers and employees for breach of fiduciary duty and other similar actions may be brought only in the Court of Chancery in the
State of Delaware, and, if an action is brought outside of Delaware, the stockholder bringing the suit will be deemed to have consented
to service of process on such stockholder’s counsel. Although we believe this provision benefits us by providing increased
consistency in the application of Delaware law in the types of lawsuits to which it applies, a court may determine that this provision
is unenforceable, and to the extent it is enforceable, the provision may have the effect of discouraging lawsuits against our directors
and officers.


Our Amended and Restated
Charter provides that the exclusive forum provision will be applicable to the fullest extent permitted by applicable law. Section
27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by
the Exchange Act or the rules and regulations thereunder. As a result, the exclusive forum provision will not apply to suits brought
to enforce any duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction.